This piece tells of the FDA approving a new combo-pill for HIV. Dovota is new formulation of 2 existing meds, dolutegravir & lamivudine. It's 1 med short (abacavir) short of being Triumeq.
The med was successful & showed less side effects than the triple combo. It hopefully will eventually have a lower price tag. It should also be easier on the bodily systems. It may just be a reformulation, but it's a step.
Cya..
No comments:
Post a Comment